MetaCap

iRadimed Corporation Company Profile

NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD

84.68-0.79 (-0.92%)

Market open · Delayed 15 min · as of Oct 8, 9:41 AM ET

iRadimed at a glance

iRadimed Corporation (NASDAQ: IRMD) is a Medical/Dental Instruments company in the Health Care sector headquartered in Orlando, FL. iRadimed is led by Mr. Roger E. Susi and employs about 166 people. The company's shares have traded publicly since 2014.

At a market capitalization of $1.08 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001325618, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does iRadimed do?

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Business description based on the company's public filings.

Company information

Legal name
iRadimed Corporation
Ticker
NASDAQ: IRMD
Industry
Medical/Dental Instruments
CEO
Mr. Roger E. Susi
Employees
166
Headquarters
12705 Ingenuity Drive, Orlando, FL, United States
Phone
407 677-8022
IPO year
2014
SEC CIK
0001325618
Latest annual report
10-K · Mar 6, 2026

Companies similar to iRadimed

IRMD peer companies
CompanyPrice% ChgMarket capCompare
TNDMTandem Diabetes Care Inc.15.60-1.51%$1.09Bvs IRMD
AORTArtivion Inc.21.38-1.20%$1.04Bvs IRMD
IARTIntegra LifeSciences Holdings Corporation13.02+0.12%$1.01Bvs IRMD
PRCTPROCEPT BioRobotics Corporation17.66-1.40%$1.01Bvs IRMD
BBNXBeta Bionics Inc.17.75-1.83%$957.55Mvs IRMD
DRTSAlpha Tau Medical Ltd.13.82-3.02%$1.28Bvs IRMD
BVSBioventus Inc. Class A12.70-0.59%$867.13Mvs IRMD
SIBNSI-BONE Inc.19.00-0.53%$851.55Mvs IRMD

Related